Declining commercial market share in facial reconstructive surgery: Implications for academic plastic surgery and training future generations.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2022 Vol.75(12) p. 4484-4493

Rochlin DH, Matros E, Sheckter CC

관련 도메인

Abstract

[BACKGROUND] As a surgical discipline without anatomic boundaries, plastic surgery overlaps with several other specialties. This study aims to measure longitudinal trends in the proportion of commercially reimbursed procedures performed by plastic surgeons compared to other specialists. We hypothesize that there is encroachment in commercial market share by anatomically defined subspecialists within otolaryngology, ophthalmology, and dermatology.

[METHODS] The IBM® MarketScan® Research Databases were queried to extract patients who underwent rhinoplasty, eyelid procedures, and skin cancer reconstruction covered by commercial insurance from 2007 to 2016 in the USA. Surgeon specialty was identified. Poisson regression modeled predictors of provider specialty for each procedure over time, adjusting for patient gender, region, facility setting, and diagnosis.

[RESULTS] A total of 430,472 rhinoplasty, eyelid, and skin cancer procedures were performed during the study period. For each year, the proportion of cases performed by plastic surgeons decreased by 2.1% for rhinoplasty compared to otolaryngologists, 2.0% for eyelid procedures compared to ophthalmologists, and 3.0% for skin cancer reconstruction compared to dermatologists (p<0.001). Plastic surgeons were less likely to perform the procedure if the underlying diagnosis or preceding procedure drew from referral bases of "anatomic" specialists, such as sinonasal disease for otolaryngologists (incidence rate ratio [IRR] 0.829), disorders of the eyelid or orbit for ophthalmologists (IRR 0.646), and Mohs excision for dermatologists (IRR 0.381) (p<0.001).

[CONCLUSIONS] Plastic surgeons are losing ground on commercially reimbursed facial reconstructive procedures historically performed by the specialty. Plastic surgeons must develop strategies to preserve the commercial market share of these procedures and avoid compromise to academic centers and resident education.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 eyelid 눈꺼풀 dict 4
시술 rhinoplasty 코성형술 dict 3
합병증 orbit scispacy 1
약물 [CONCLUSIONS] Plastic surgeons are scispacy 1
약물 extract C1555707
extract - ActClassContainer
scispacy 1
약물 [BACKGROUND] scispacy 1
약물 [RESULTS] A scispacy 1
약물 [IRR] 0.829 scispacy 1
질환 skin cancer C0007114
Malignant neoplasm of skin
scispacy 1
질환 disorders of the eyelid or orbit scispacy 1
질환 sinonasal disease scispacy 1
기타 patients scispacy 1
기타 patient scispacy 1

MeSH Terms

Humans; Surgery, Plastic; Plastic Surgery Procedures; Otolaryngology; Skin Neoplasms; Social Responsibility

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문